Nicotine free Feellife Falling Rain E LIQUID from Tobacco Series By Feellife
An appreciable concentrate on its own as well as in gourmet recipe, which requires a sufficient maturation time.
This flavor contains tobacco absolute and extract.
Capacity: 10ml,15ml, 30ml, 60ml, 120ml
Nicotine Strength: 0mg/g, 8mg/g, 12mg/g, 18mg/g, 24mg/g
Ingredients: Herbal extract/Glycerol/ Propylene glycol/Flavorings/Nicotine
Bottle type: Child proof cap
Package: top-grade plastic package
Certificates: TUV, MSDS, JRFL, ISO, FDA, GMP, SGS
We produce :
Feellife free nicotine Falling Rain E LIQUID from tobacco series
Feellife 10ml nicotine Falling Rain E LIQUID strength 8mg from tobacco series
Feellife 30ml nicotine Falling Rain E juice strength12mg from tobacco series
Feellife 60ml nicotine Falling Rain E LIQUID strength 16mg from tobacco series
Feellife 30ml nicotine Falling Rain E LIQUID strength 18mg from tobacco series
Feellife 30ml nicotine Djarum Super Falling Rain EJUICE strength 24mg from tobacco series
We want to create the best Tobacco Series e-Liquids possible. Here is our classic Tobacco Series Range: the finest, premium quality, all-natural and pharmaceutically approved ingredients. This is the reason why we are known worldwide for our first-class products.
All e-Liquids undergo independent quality control and are GCC and TPD compliant, with many international certificates. Our production line uses only high-quality and environmentally friendly ingredients. In order to encompass the best flavours possible, we obtain from raw fruit extracts and genuine tobacco extracts. The ingredients used in our products promote the precise taste and natural elements which is to define our Silver Label flavours.
Feellife uses only high-quality and environment-friendly ingredients that are free of harmful substances.
Made in China
Molecular technology secures natural extracts
High-quality pharmaceutical grade solvents
Natural flavour extracts
Fully TPD Compliant
Huge range of flavours
Since set up in 2009, FEELLiFE has focused on the research and development and production of e-liquid, rapidly developed into the top global e-liquid OEM manufacturer, providing high-quality e-liquid products for many well-known e-liquid brands all over the world.
With modern international standard factory, pharmaceutical grade dust-free workshop and assembly line, FEELLiFE make sure every bottle of e-liquid to meet the requirements of high quality.
Factory Address: 202 North California Ave, City of Industry CA 91744 U.S.A.
Hungary: Perceived E-Cig Benefits Amongst Adult Vapers
The study titled Perceived health effects of vaping among Hungarian adult e-cigarette-only and dual users: a cross-sectional internet survey, administered a web-based survey to 1042 adults in 2015. Participants were asked to report any AEs and physiological changes since they switched from smoking to vaping or while dually using e-cigarettes and combustible cigarettes.
The compiled data indicated that non-surprisingly dual users were significantly more likely to report AEs of vaping than e-cigarette-only users @ 26.2% vs. 11.8%. Similarly, those using only e-cigarettes were more likely to experience health improvements than dual users. Also, those individuals who were former heavy smokers were more likely to report positive changes in sensory and physical functioning, than those who were not.
E-cig-only users more likely to report benefits than dual users
“The majority of e-cigarette-only users reported more perceived beneficial changes in physiological functions and fewer AEs than dual users. Perceived short-term benefits of e-cigarette use may reinforce users despite the uncertainty of long-term health consequences,” read the study Abstract.
“Health professionals should provide balanced information regarding the possible short- and long-term positive and negative health effects of e-cigarette use during consultations with patients,” concluded the researchers.
Post time: Mar-28-2019
More Junk Science Linking Vaping to Heart Disease
The study titled E-Cigarettes Linked to Heart Attacks, Coronary Artery Disease and Depression, used data from the National Health Interview Survey (NHIS) and concluded that ” adults who report puffing e-cigarettes, or vaping, are significantly more likely to have a heart attack, coronary artery disease and depression compared with those who don’t use them or any tobacco products.”
These conclusions were based on a cross-sectional analysis of data from the 2014, 2016, and 2017 National Health Interview Surveys, in which respondents were asked to report whether they had ever been diagnosed with having had a heart attack, coronary artery disease, or depression, and whether they used e-cigarettes and/or cigarettes.
A correlation is not causation
The researchers found that respondents who reported vaping were more likely to have ever had a heart attack, been told they have coronary artery disease, or to have ever been diagnosed with depression. However, just like similar studies before it, there is one major problem with this study: the researchers have no idea which came first: the vaping or the heart attack, heart disease, or depression.
This is an important factor, and leaving it out makes the findings meaningless. Research has shown that most vapers are former smokers, therefore all of all the above health conditions could have been caused by their smoking and even prompted them to switch to the safer alternatives.
More flawed research
In line with this, only last month, renowned cardiologist and anti-smoking researcher Dr. Konstantinos Farsalinos, responded to similar allegations made by another recently published study and conference abstract.
Released last month, this latter study concluded that “Daily e-cigarette use, adjusted for smoking conventional cigarettes as well as other risk factors, is associated with increased risk of myocardial infarction.” Similarly the media coverage of the conference abstractstated that “E-cigarettes linked to higher risk of stroke, heart attack, diseased arteries.”
Dr. Konstantinos Farsalinos, criticised these allegations saying that both conclusions are wrong and “constitute epidemiological malpractice and misinformation.” He explained that being cross-sectional surveys, meaning that they asked participants if they have heart disease and if they use e-cigarettes, such studies provide no information as to whether the participants initiated e-cigarette use before or after the development of the disease, or for how long.
As with the former study, this means that the participants could have easily started vaping following a heart disease diagnosis, in order to quit smoking and improve their health.
The study authors must know that these claims are erroneous
Additionally added the cardiologist, he is confident that both the authors of the published study and the American Heart Association, which released the press statement for the conference abstract, are well aware of these basic epidemiological principles, as any scientist would.
“This is simple, basic knowledge for a medical student, let alone for acknowledged scientists. And they know that the statements about “increased risk” are wrong. So, why do they use these statements? Perhaps we should ask them…” concluded Farsalinos.
The cardiologist concluded that these studies do not really provide any information about any risk associated with the use of e-cigarettes, despite claiming that they do. “They do not prove an increased risk and of course they do not prove that no such risk exists. They simply cannot address the question of whether e-cigarettes increase the risk for heart disease or not,” he said.
By Diane Caruana
Post time: Mar-27-2019